Are you a new member? Sign up now
Login area
| Sign up
close
VIOSTAN AM PLUS 160/10/12.5 - - 30
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C09DX01 | G | Valsartan - 160mg, Amlodipine - 10mg, Hydrochlorothiazide - 12.5mg | 11338 | 10322/1 | VIOSTAN AM PLUS 160/10/12.5 | 30 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 1,196,020 L.L | 23.08 | B | 2/5/2024 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C09DX01 | B | Valsartan - 160mg, Amlodipine - 10mg, Hydrochlorothiazide - 12.5mg | 11782 | 138223/1 | EXFORGE HCT | 28 | Tablet, film coated | Oral | Khalil Fattal & Fils S.A.L. | Novartis Farma SpA | Italy | 1,417,754 L.L | 23.08 | A2 | Novartis Pharma AG | Switzerland | 2/5/2024 | 0 | |
| C09DX01 | G | Valsartan - 160mg, Amlodipine - 10mg, Hydrochlorothiazide - 12.5mg | 11255 | 6220/1 | LOTEVAN PLUS | 30 | Tablet, film coated | Oral | Mersaco | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 911,125 L.L | 23.08 | A2 | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024